Bluejay Diagnostics, Inc. Convertible Debt, Current
Bluejay Diagnostics, Inc. (BJDX) had Convertible Debt, Current of $3.97 million as of 2021-09-30, per its 10-Q filed 2021-12-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2023-03-20
- 2021-09-30: Convertible Debt, Current $3.97M.
- 2021-08-04: Convertible Debt, Current $1.50M.
| Period end | Convertible Debt, Current |
|---|---|
| 2021-09-30 | $3.97M 10-Q · filed 2021-12-16 |
| 2021-08-04 | $1.50M 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |